SNORD36A: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORD36A

NCBI ID: G26815

Other Name(s): Small nucleolar RNA, C/D box 36A | U36a | small nucleolar RNA, C/D box 36A | RNU36A

SNORD36A: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the key functions of snRNA is to help maintain the stability of chromatin by base pairing with specific DNA sequences . One of the most well-known snRNAs is SNORD36A, which is a 22-nt RNA molecule located in the C/D box region on chromosome 18.

SNORD36A is a key player in the regulation of gene expression and has been implicated in a wide range of cellular processes. One of its most well-documented functions is its role in regulating microRNA (miRNA) levels, which are small non-coding RNAs that play a critical role in post-transcriptional gene regulation. Specifically, SNORD36A has been shown to act as a negative regulator of the miRNA pathway, helping to keep miRNA levels in check and prevent excessive or impropermiRNA formation.

In addition to its role in regulating miRNA levels, SNORD36A has also been shown to play a critical role in the regulation of gene expression more broadly. One of its most well-documented functions is its role in regulating the stability of pre-mRNA, a critical step in the translation of gene expression information into protein. By interacting with specific protein(s) and helping to maintain the stability of pre-mRNA, SNORD36A helps to ensure that the information in the gene's expression is properly translated into protein.

SNORD36A's role in the regulation of gene expression is also important for understanding the mechanisms of cancer. Many studies have suggested that changes in miRNA levels, often due to SNORD36A's activity, can contribute to the development and progression of cancer. For example, altered miRNA levels have been implicated in the development of various types of cancer, including breast, ovarian, and colorectal cancers.

Furthermore, SNORD36A has also been shown to play a critical role in the regulation of cellular processes that are important for the development and maintenance of tissues, such as the development of tissues and organs, and the regulation of cell death. For example, studies have suggested that SNORD36A helps to control the production of cell-cycle proteins, which are important for the regulation of cell growth and division.

SNORD36A is also of interest as a potential drug target. The miRNA pathway is a well-established target for drug development, and SNORD36A's role in this pathway makes it a potential candidate for drug development. Several studies have shown that inhibitors of SNORD36A have the potential to suppress the production of certain types of cancer cells, including breast, ovarian, and colorectal cancer cells.

In addition to its potential as a drug target, SNORD36A is also a potential biomarker for the diagnosis and prognosis of cancer. The miRNA pathway is a well-established biomarker for cancer, and changes in miRNA levels, often due to SNORD36A's activity, can be used as a diagnostic or prognostic marker for cancer. Several studies have shown that changes in miRNA levels are associated with the development and progression of cancer, and that these changes can be used as biomarkers for the diagnosis and prognosis of cancer.

SNORD36A is a small molecule that has been shown to play a critical role in the regulation of gene expression and has the potential to be a drug target or biomarker for cancer. Further research is needed to fully understand its functions and its potential as a drug

Protein Name: Small Nucleolar RNA, C/D Box 36A

More Common Targets